(-0.05%) 5 305.50 points
(-0.02%) 40 134 points
(-0.06%) 18 494 points
(0.90%) $82.08
(-1.28%) $1.696
(0.63%) $2 226.60
(0.20%) $24.80
(0.51%) $914.35
(0.36%) $0.927
(0.55%) $10.83
(0.17%) $0.793
(-0.16%) $92.30
5 days till quarter result
(bmo 2024-04-02)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound...
Stats | |
---|---|
Today's Volume | 1.86M |
Average Volume | 15.71M |
Market Cap | 5.67M |
EPS | $-0.0400 ( 2023-11-13 ) |
Next earnings date | ( $-0.0300 ) 2024-04-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0300 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-04 | Slilaty Steve N. | Buy | 100 000 | Series B Preferred Stock |
2024-02-08 | Slilaty Steve N. | Buy | 20 000 | Series B Preferred Stock |
2024-01-26 | Beaudoin Marc | Buy | 0 | |
2022-11-30 | Sebaaly Camille | Buy | 30 000 | Common Stock |
2022-10-20 | Chamoun Malek | Sell | 0 | Common Stock, par value $0.001 per share |
INSIDER POWER |
---|
100.00 |
Last 67 transactions |
Buy: 1 074 426 098 | Sell: 315 420 609 |
Volume Correlation
Sunshine Biopharma, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sunshine Biopharma, Inc. Correlation - Currency/Commodity
Sunshine Biopharma, Inc. Financials
Annual | 2022 |
Revenue: | $4.35M |
Gross Profit: | $1.70M (39.04 %) |
EPS: | $-1.760 |
Q3 | 2023 |
Revenue: | $5.96M |
Gross Profit: | $1.99M (33.41 %) |
EPS: | $-0.0254 |
Q2 | 2023 |
Revenue: | $5.56M |
Gross Profit: | $1.95M (35.12 %) |
EPS: | $-0.0356 |
Q1 | 2023 |
Revenue: | $4.89M |
Gross Profit: | $1.83M (37.35 %) |
EPS: | $-0.0773 |
Financial Reports:
No articles found.
Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators